AR120398A1 - Lavados de salinidad elevada durante cromatografía de intercambio catiónico para eliminar impurezas relacionadas con el producto - Google Patents

Lavados de salinidad elevada durante cromatografía de intercambio catiónico para eliminar impurezas relacionadas con el producto

Info

Publication number
AR120398A1
AR120398A1 ARP200103071A ARP200103071A AR120398A1 AR 120398 A1 AR120398 A1 AR 120398A1 AR P200103071 A ARP200103071 A AR P200103071A AR P200103071 A ARP200103071 A AR P200103071A AR 120398 A1 AR120398 A1 AR 120398A1
Authority
AR
Argentina
Prior art keywords
cation exchange
product related
related impurities
exchange chromatography
high salinity
Prior art date
Application number
ARP200103071A
Other languages
English (en)
Inventor
Malhar R Ambhaikar
Luis Diaz
Natalia Gomez
Benjamin J Tillotson
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AR120398A1 publication Critical patent/AR120398A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424—Elution mode
    • B01D15/426—Specific type of solvent
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/145—Ultrafiltration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2315/00—Details relating to the membrane module operation
    • B01D2315/16—Diafiltration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/64—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente se refiere a métodos para eliminar impurezas relacionadas con el producto de punto isoeléctrico bajo durante operaciones de purificación de intercambio catiónico.
ARP200103071A 2019-11-07 2020-11-05 Lavados de salinidad elevada durante cromatografía de intercambio catiónico para eliminar impurezas relacionadas con el producto AR120398A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962931874P 2019-11-07 2019-11-07

Publications (1)

Publication Number Publication Date
AR120398A1 true AR120398A1 (es) 2022-02-09

Family

ID=73598212

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200103071A AR120398A1 (es) 2019-11-07 2020-11-05 Lavados de salinidad elevada durante cromatografía de intercambio catiónico para eliminar impurezas relacionadas con el producto

Country Status (14)

Country Link
US (1) US20220372071A1 (es)
EP (1) EP4055042A1 (es)
JP (1) JP2022554283A (es)
KR (1) KR20220092958A (es)
CN (1) CN114651007A (es)
AR (1) AR120398A1 (es)
AU (1) AU2020377919A1 (es)
BR (1) BR112022008782A2 (es)
CA (1) CA3160208A1 (es)
CL (1) CL2022001169A1 (es)
IL (1) IL292602A (es)
MX (1) MX2022005594A (es)
TW (1) TW202132323A (es)
WO (1) WO2021091933A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012125735A1 (en) * 2011-03-15 2012-09-20 Abott Laboratories An integrated approach to the isolation and purification of antibodies
EP3145951A1 (en) * 2014-06-24 2017-03-29 InSight Biopharmaceuticals Ltd. Methods of purifying antibodies
JP6699085B2 (ja) * 2015-03-25 2020-05-27 東ソー株式会社 Ｆｃ結合性タンパク質の精製方法
EP3472177A2 (en) * 2016-06-17 2019-04-24 F. Hoffmann-La Roche AG Purification of multispecific antibodies
CN110305217B (zh) * 2018-03-27 2022-03-29 广州爱思迈生物医药科技有限公司 双特异性抗体及其应用

Also Published As

Publication number Publication date
MX2022005594A (es) 2022-06-09
KR20220092958A (ko) 2022-07-04
BR112022008782A2 (pt) 2022-07-26
TW202132323A (zh) 2021-09-01
WO2021091933A1 (en) 2021-05-14
CL2022001169A1 (es) 2023-01-27
AU2020377919A1 (en) 2022-06-16
EP4055042A1 (en) 2022-09-14
CN114651007A (zh) 2022-06-21
IL292602A (en) 2022-07-01
JP2022554283A (ja) 2022-12-28
CA3160208A1 (en) 2021-05-14
US20220372071A1 (en) 2022-11-24

Similar Documents

Publication Publication Date Title
IL261846B (en) Purification of glucagon-like peptide 1 analogs
CL2020003254A1 (es) Procedimiento para la deshidratación de agua fangosa acuosa
MX2018015654A (es) Cromatografía de interacción hidrofóbica para la purificación de oligonucleótidos.
IL278932A (en) Process for the synthesis of (S)-3-amino-4-(difluoromethylnyl)cyclopent-1-ene-1-carboxylic acid
MY191884A (en) Oil purification process
SA518391338B1 (ar) عملية لإزالة مركبات الكبريت من تيارات عملية
PL3877358T3 (pl) Sposób wytwarzania podstawionych aminoalkoholi
EA201790613A8 (ru) Триазольные соединения в качестве блокаторов кальциевых каналов т-типа
MX2017013143A (es) Uso de acido alcanosulfonico para limpieza en las industrias azucareras.
EP3709986A4 (en) NEW SUBSTITUTED BIARYL COMPOUNDS USED AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS
EA201792640A1 (ru) Устойчивые к действию протеазы липидированные аналоги glp-1
FR3050942B1 (fr) Procede de purification d'acide chlorhydrique
AR120398A1 (es) Lavados de salinidad elevada durante cromatografía de intercambio catiónico para eliminar impurezas relacionadas con el producto
EP4063330A4 (en) MULTI-STAGE APPARATUS FOR PRODUCING MAGNETIZED WATER
MX2019005785A (es) Proceso para la purificacion de 1-(4-clorofenil)pirazol-3-ol.
ZA202205211B (en) Apparatus for purifying water
MX2020010343A (es) Proceso para la purificacion de biocomposiciones complejas.
PL3823952T3 (pl) Oczyszczanie kwasu lewulinowego
EP3851446A4 (en) PEPTIDE PURIFICATION PROCESS USING A SULFONATE COMPOUND
SG11202101575TA (en) Process for the production of high purity isobutylene
ES2975333T3 (es) Un proceso para la purificación de derivados policíclicos de carbamoilpiridona protegidos
PL3793971T3 (pl) Optymalizacja systemu odzyskiwania 2-etyloheksanolu za pomocą intensyfikacji procesu
WO2016202808A3 (en) NEW SYNTHESIS OF TAPENTADOL-HCl INTERMEDIATES
CL2022001168A1 (es) Acondicionamiento de la carga con salinidad elevada durante la cromatografía de intercambio catiónico para eliminar impurezas relacionadas del producto
EA201791098A1 (ru) Способ синтеза производных бензазепина